Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference21 articles.
1. U.S. Pharmacopeia National Formulary, Betadex Sulfobutyl Ether Sodium, NF33 (2015) 6546–6550.
2. Cyclodextrins;Stella;Toxicol. Pathol.,2008
3. S. Beato, M. Bresciani, S.R. Croy, F.X. Muller, Pharmaceutical formulations comprising Vestipitant, PCT Int. Appl. (2012) WO2012175434 A1.
4. Intravenous pharmacokinetics, local tolerability, and hemolysis of an SBE7-β-cyclodextrin formulation of the Neurokinin-I receptor antagonist Vestipitant;Bringandi;Clin. Pharmacol. Drug Dev.,2014
5. Application of sulfobutylether-β-cylcodextrin with specific degrees of substitution for the enantioseparation of pharmaceutical mixtures by capillary electrophoresis;Skanchy;Electrophoresis,1999
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献